Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
D
303810
vs
K
KOSPI 200
Over the past 12 months, DongKook Life Science Co Ltd has underperformed KOSPI 200, delivering a return of +13% compared to KOSPI 200's +116% growth.
Stocks Performance
303810 vs KOSPI 200
Performance Gap
303810 vs KOSPI 200
Performance By Year
303810 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
DongKook Life Science Co Ltd
Glance View
DongKook Life Science Co., Ltd. engages in the manufacturing and selling of pharmaceutical products and distributing medical devices and diagnostic equipment. The company is headquartered in Seoul, Seoul and currently employs 203 full-time employees. The company went IPO on 2025-02-17. The firm is principally engaged in the production and sale of contrast agents such as X-ray contrast agents, magnetic resonance imaging (MRI) contrast agents as well as others. In addition, the Company is engaged in the distribution and sale of medical equipment and medical devices.